Onconetix, Inc. (ONCO) vs Silexion Therapeutics Corp (SLXN)
- Onconetix, Inc. ONCO 0.48 −12.73%
- Silexion Therapeutics Corp SLXN 0.15 −21.05%
Onconetix, Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Onconetix, Inc. and Silexion Therapeutics Corp are of similar size ($2.9M and $2.7M). Silexion Therapeutics Corp has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. Silexion Therapeutics Corp has the higher net margin (0.00% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 13 metrics below, Onconetix, Inc. leads on 8 and Silexion Therapeutics Corp on 5.
Valuation
Profitability
| Metric | ONCO | SLXN | Biotechnology median |
|---|---|---|---|
| Gross margin | 80.38% | — | 65.16% |
| Operating margin | (2,524.73%) | 0.00% | 0.00% |
| Net margin | (1,578.60%) | 0.00% | 0.00% |
| Free cash flow margin | (1,595.90%) | 0.00% | 0.00% |
| Return on equity | (105.23%) | (17,021.95%) | (56.36%) |
| Return on assets | (57.37%) | (277.96%) | (48.04%) |
| Return on invested capital | (135.42%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack